Skip to main content
. 2018 Aug 29;9(11):1429–1436. doi: 10.1111/1759-7714.12855

Table 3.

Characteristics of follow‐up patients

Characteristics All (n = 118) Sarcopenia (n = 108) No sarcopenia (n = 10) P
Age, years 65.8 ±9.9 66.4 ±9.7 60.1 ±10.4 0.043
Gender 0.371
Male 80 67% 72 66% 8 80%
Female 39 33% 37 34% 2 20%
Weight, kg 65 55–77 64 55–77.5 69 60–74.8 0.612
Height, cm 173 165–179 173 164.5–179 173 164.5–178.3 0.799
BMI, kg/m2 22.3 20.0–24.9 22 19.6–24.7 23.5 21.7–25.6 0.427
Weight loss, kg 10 7–17 10 7.5–17 10 5–15 0.58
CCI 6.8 ±2.1 6.8 ±1.6 7.1 ±1.6 0.725
Muscle parameters
TMA, m2 101.6 85.1–119.1 97.1 83.2–116.4 131.9 115.9–161.7 0.001
SMI, m2/cm2 35.4 29.6–40.0 33.5 28.8–38.3 45.3 40.0–53.4 0.000
SMI Change −4.1 −8.9‐(−0.3) −4.3 −9.1‐(−0.8) −1.3 −5.4‐1.3 0.073

Cross‐sectional total muscle area (TMA) at the level of L3.

Skeletal muscle index (SMI) = TMA/(height2).

BMI, body mass index; CCI, Charlson Comorbidity Index.